3,4,3′-Tri-O-methylellagic acid as an anticancer agent: in vitro and in silico studies

We report a natural product compound isolated from Syzygium polycephalum known as 3,4,3′-tri-O-methylellagic acid (T-EA) as a candidate drug for cancer treatment. The characterization of the isolated T-EA compound was carried out using various spectroscopic methods. The in vitro evaluation showcased...

Descripción completa

Detalles Bibliográficos
Autores principales: Wardana, Andika Pramudya, Abdjan, Muhammad Ikhlas, Aminah, Nanik Siti, Fahmi, Mochamad Zakki, Siswanto, Imam, Kristanti, Alfinda Novi, Saputra, Mirza Ardella, Takaya, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580503/
https://www.ncbi.nlm.nih.gov/pubmed/36321100
http://dx.doi.org/10.1039/d2ra05246f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580503/
https://www.ncbi.nlm.nih.gov/pubmed/36321100
http://dx.doi.org/10.1039/d2ra05246f

Ejemplares similares